ÅǸ޴º
Á¦¸ñ | Cost-effectiveness of bevacizumab-based therapy versus cisplatin plus pemetrexed for the first-line treatment of advanced non-squamous NSCLC in Korea and Taiwan | µî·ÏÀÏ | 20150827 | ´Ù¿î·Îµå | |
---|---|---|---|---|---|
Cost-effectiveness of bevacizumab-based therapy versus cisplatin plus pemetrexed for the first-line treatment of advanced non-squamous NSCLC in Korea and Taiwan
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 7/Suppl. :22-33,2011 |
Copyright ¨Ï chamc, All rights reserved.